MC

Megha Chauhan

Active Director Director DIN 10930665
DIN 10930665 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value •••• Premium profile

About Megha Chauhan

Data last updated:

Megha Chauhan is a Director at Invasion Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Invasion Pharmaceuticals Private Limited reported revenue of ₹1.62 Cr (FY 2025).

DIN 10930665
Primary Designation Director
Industry Pharma
First Appointment 31 Jan 2025
Oldest Company Age 15 yrs
Largest company Invasion Pharmaceuticals Private Limited · ₹1.62 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Jan 20252011₹1.62 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Invasion Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Megha Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Megha Chauhan

Megha Chauhan currently holds 1 directorship: Invasion Pharmaceuticals Private Limited (Director, since 31 Jan 2025, revenue ₹1.62 Cr (FY 2025)).

Megha Chauhan was first appointed on 31 Jan 2025 as Director at Invasion Pharmaceuticals Private Limited.

The current boards of Megha Chauhan's companies include Digvijaysinh Mahendrasinh Zala (Invasion Pharmaceuticals Private Limited), Shailesh Narottambhai Chauhan (Invasion Pharmaceuticals Private Limited), Vidhi Dipak Vanza (Invasion Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available